What is the drug of choice for treating syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug of Choice for Syphilis

Parenteral penicillin G is the drug of choice for treating all stages of syphilis, with benzathine penicillin G being the preferred formulation for most cases. 1, 2

Treatment by Stage

Early Syphilis (Primary, Secondary, and Early Latent)

  • Benzathine penicillin G 2.4 million units IM as a single dose is the recommended treatment 2, 3, 4
  • This single-dose regimen has been proven effective through 50 years of clinical experience 1
  • Early latent syphilis is defined as infection acquired within the preceding year, documented by seroconversion, fourfold titer increase, recent symptoms, or exposure to a partner with documented early syphilis 2

Late Latent Syphilis and Latent Syphilis of Unknown Duration

  • Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals 2, 3
  • This extended regimen is necessary due to the longer duration of infection 2

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 2, 3
  • This is the only acceptable regimen for neurosyphilis, which can occur at any stage of infection 4

Alternative Treatments for Penicillin-Allergic Patients

Non-Pregnant Adults

  • For early syphilis (primary, secondary, early latent): Doxycycline 100 mg orally twice daily for 14 days 2, 5, 6
  • For late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days 2, 3, 6
  • Ceftriaxone 1 gram IV/IM daily for 10 days is a reasonable alternative based on randomized trial data showing comparable efficacy to benzathine penicillin 2
  • Azithromycin should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures 2

Critical Exception: Pregnancy and Neurosyphilis

  • Penicillin is the ONLY therapy with documented efficacy for preventing maternal transmission and treating fetal infection 1, 2, 5
  • Pregnant women and neurosyphilis patients who report penicillin allergy MUST undergo desensitization followed by penicillin treatment—no alternatives are acceptable 1, 2, 5
  • This is non-negotiable because no other antibiotic has been proven to prevent congenital syphilis 2

Special Populations

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients for all stages of syphilis 2, 5
  • Limited data suggest no benefit to multiple doses of benzathine penicillin for early syphilis in HIV-infected patients compared to a single dose 2
  • However, closer follow-up is mandatory to detect potential treatment failure or disease progression 2
  • HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 1, 2

Critical Pitfalls to Avoid

  • Never use oral penicillin preparations—they are completely ineffective for syphilis treatment 1, 5
  • Never substitute inadequate alternatives in pregnancy—only penicillin prevents congenital syphilis 2
  • Do not rely solely on treponemal test antibody titers to assess treatment response, as they correlate poorly with disease activity 1, 2
  • Never switch between different nontreponemal test methods (RPR vs VDRL) when monitoring response—results cannot be directly compared 2, 5
  • Never skip CSF examination before treating tertiary syphilis—missing neurosyphilis leads to treatment failure 5

Important Clinical Considerations

Jarisch-Herxheimer Reaction

  • An acute febrile reaction frequently accompanied by headache and myalgia may occur within 24 hours after any syphilis therapy 1, 2, 3
  • This reaction occurs most often in patients with early syphilis 1
  • In pregnant women, this reaction may precipitate premature labor or fetal distress during the second half of pregnancy 2
  • Patients should be informed about this possible adverse reaction, though antipyretics have not been proven to prevent it 1

Follow-Up Protocol

  • Quantitative nontreponemal serologic tests (RPR or VDRL) should be repeated at 3,6,12, and 24 months after treatment 2, 5
  • For primary/secondary syphilis: Expect a fourfold decline in titer within 6 months 2, 5
  • For late syphilis: Expect a fourfold decline in titer within 12-24 months 2, 5
  • Treatment failure is defined as failure of nontreponemal test titers to decline fourfold within these timeframes 2, 3

Management of Sex Partners

  • Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively even if seronegative 1, 2
  • Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Syphilis Diagnosis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.